The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis

(2012) Luisa M. Villar   ARCHIVES OF NEUROLOGY

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

(2012) Markus C Kowarik et al.   Journal of Neuroinflammation

Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis

(2012) E. Gray et al.   Multiple Sclerosis Journal

B cells and antibodies in multiple sclerosis pathogenesis and therapy

(2012) Markus Krumbholz et al.   Nature Reviews Neurology

Antigen microarrays identify CNS-produced autoantibodies in RRMS

(2012) F. J. Quintana et al.   NEUROLOGY

MicroRNAs in the CSF: Macro-advance in MS?

(2012) E. Meinl et al.   NEUROLOGY

Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study

(2012) A. Haghikia et al.   NEUROLOGY

Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

(2012) Rajneesh Srivastava et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis

(2012) Isabel Brecht et al.   PLoS One

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update

(2012) Rupasri Mandal et al.   Genome Medicine

Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis

(2011) Hayrettin Tumani et al.   ANNALS OF NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis

(2011) Ajit Singh Dhaunchak et al.   ANNALS OF NEUROLOGY

Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis

(2011) Lionel Blanchet et al.   BMC BIOINFORMATICS

Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria

(2011) H. Lassmann et al.   BRAIN

In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study

(2011) Axel Petzold et al.   BRAIN

B cells undergo unique compartmentalized redistribution in multiple sclerosis

(2011) Jürgen Haas et al.   JOURNAL OF AUTOIMMUNITY

Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis

(2011) Kathryn M. Brennan et al.   JOURNAL OF NEUROIMMUNOLOGY

Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin

(2011) Birgit Obermeier et al.   JOURNAL OF NEUROIMMUNOLOGY

Proteomics technologies for biomarker discovery in multiple sclerosis

(2011) Vaibhav Singh et al.   JOURNAL OF NEUROIMMUNOLOGY

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

(2011) S. Jarius et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis

(2011) J Frederiksen et al.   Multiple Sclerosis Journal

Autoantigen discovery with a synthetic human peptidome

(2011) H Benjamin Larman et al.   NATURE BIOTECHNOLOGY

Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS

(2011) M. C. Kowarik et al.   NEUROLOGY

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

(2010) Manuel Comabella et al.   BRAIN

Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis

(2010) Lucas Schirmer et al.   BRAIN PATHOLOGY

2D DIGE of the cerebrospinal fluid proteome in neurological diseases

(2010) Hayrettin Tumani et al.   Expert Review of Proteomics

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM

(2010) Patrizia Sola et al.   Multiple Sclerosis Journal

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

(2010) Mohsen Khademi et al.   Multiple Sclerosis Journal

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid

(2009) Gregory P. Owens et al.   ANNALS OF NEUROLOGY

The relation between inflammation and neurodegeneration in multiple sclerosis brains

(2009) Josa M. Frischer et al.   BRAIN

Neurofilament ELISA validation

(2009) Axel Petzold et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The prognostic significance of cerebrospinal fluid in multiple sclerosis

(2009) Sasitorn Siritho et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebrospinal fluid biomarkers in multiple sclerosis

(2009) Hayrettin Tumani et al.   NEUROBIOLOGY OF DISEASE

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome

(2009) Johannes Brettschneider et al.   PLoS One

Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals

(2009) T. Derfuss et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis

(2008) J. M. Anderson et al.   BRAIN

Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies

(2008) Hans‐Christian von Büdingen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

(2008) S Jarius et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients

(2008) F G Joseph et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets

(2008) May H. Han et al.   NATURE

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis

(2008) Birgit Obermeier et al.   NATURE MEDICINE

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

(2008) O. Stuve et al.   NEUROLOGY